Anika Therapeutics Statistics
NASDAQ: ANIKHealth CareMedical/Dental InstrumentsUSD
19.04-0.49 (-2.51%)
Market open · Delayed 15 min · as of Oct 8, 10:40 AM ET
Anika Therapeutics by the numbers
Anika Therapeutics has a market capitalization of $254.8 million based on 13.38M shares outstanding. With trailing EPS of $-0.23, Anika Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.4% below its 50-day average and 25.9% above its 200-day average.
Average daily trading volume is 98.57K shares, or about $1.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANIK valuation vs. peer median
| Metric | ANIK | Peer median | Difference |
|---|---|---|---|
| Market cap | $254.81M | $253.00M | +1% |
| Avg. volume | 98.57K | 160.02K | -38% |
Peer median across 8 companies: INFU, OSUR, TMCI, PROF, MOBI, UTMD, CLPT, KTWO.
Valuation
- Market cap
- $254.81M
- Forward P/E
- 20.04
- EPS (TTM)
- $-0.23
- Shares outstanding
- 13.38M
Price and trading
- Previous close
- 19.53
- Open
- 19.39
- Day range
- 18.90 – 19.39
- 52-week range
- 8.67 – 22.88
- 52-week change
- +114.85%
- Beta
- —
- Volume
- 11.53K
- Average volume
- 98.57K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 254.81M
- Forward Pe
- 20.04
- Eps
- -0.23
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 22.88
- Week52 Low
- 8.67
- Avg Volume
- 98,570.00
- Shares Outstanding
- 13.38M
- Ma50
- 20.57
- Ma200
- 15.13
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -16.78%
- Pct From52w Low
- 119.61%